Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Azacitidine
Decitabine
Gleevec
Imatinib Mesylate
Imkeldi
Inqovi
Lenalidomide
Onureg
Revlimid
Rytelo
Tibsovo
Vidaza
Myelodysplastic syndromes are a group of disorders caused by poorly formed blood cells or ones that don’t work properly. Myelodysplastic syndromes result from something amiss in the spongy material inside your bones where blood cells are made (bone marrow). (Source: Mayo Clinic)
Eligibility Criteria
Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Medications Covered
Azacitidine
Decitabine
Gleevec
Imatinib Mesylate
Imkeldi
Inqovi
Lenalidomide
Onureg
Revlimid
Rytelo
Tibsovo
Vidaza
Disease Description
Myelodysplastic syndromes are a group of disorders caused by poorly formed blood cells or ones that don’t work properly. Myelodysplastic syndromes result from something amiss in the spongy material inside your bones where blood cells are made (bone marrow). (Source: Mayo Clinic)